Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies

被引:2
作者
Montella, Marco [1 ]
Franco, Renato [1 ]
Aquino, Gabriella [2 ]
Ronchi, Andrea [1 ]
Zito Marino, Federica [1 ]
Di Napoli, Marilena [3 ]
Pignata, Sandro [3 ]
Cozzolino, Immacolata [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Mental & Phys Hlth & Prevent Med, Pathol Unit, Naples, Italy
[2] IRCCS, Ist Nazl Studio & Cura Tumori Fdn G Pascale, Pathol Unit, Naples, Nepal
[3] IRCCS, Ist Nazl Studio & Cura Tumori Fdn G Pascale, Div Med Oncol, Dept Urogynaecol Oncol, Naples, Italy
关键词
bone metastasis; cytology; FNAC; renal cell carcinoma; Xp11; translocation; FINE-NEEDLE-ASPIRATION; BREAK-APART FISH; GENE FUSION; CATHEPSIN K; TFE3; FEATURES; LESIONS; EXPRESSION; NEOPLASMS; BIOPSY;
D O I
10.1002/dc.24587
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Renal cell carcinoma (RCC) constitutes 3% of all cancers, with a higher incidence in patients with age between 60 and 70 years. RCC frequently present as a metastatic tumor at diagnosis, and bones represent one of the most frequent sites. Many cases, mainly in young patients, includes the Xp11 translocation RCC. The cytological diagnosis of Xp11 translocation RCC in adult population it is rarely performed, likely for the morphological overlap with other adult renal cell carcinoma subtypes. Methods We retrospectively analyze a series of 92 adult patients with metastatic bone tumors, diagnosed on fine-needle aspiration cytology (FNAC) samples, focusing mainly on the cytological, immunophenotypic and molecular features of Xp11 translocation RCC. Results In our series 6 of 92 (6.5%) cases were metastatic RCC (mRCC), among them 2 cases were metastasis from Xp11translocation RCC. Those cases showed a bloody background, with several groups of atypical cells arranged in syncytial groups or in papillary groups composed by atypical cells with abundant cytoplasm, with scattered clear cells. TFE3 was positive on immunocytochemical analysis and specific translocation t(Xp11.23) was detected by FISH analysis. Conclusions In adult patients with mRCC, it is necessary to consider also Xp11 translocation RCC among the diagnostic hypotheses. FNAC represents a valid tool to investigate bone lesions but cytological features of Xp11 translocation RCC are still poorly described and must necessarily be better defined.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 33 条
  • [1] A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)
    Argani, P
    Lui, MY
    Couturier, J
    Bouvier, R
    Fournet, JC
    Ladanyi, M
    [J]. ONCOGENE, 2003, 22 (34) : 5374 - 5378
  • [2] Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions -: A sensitive and specific immunohistochemical assay
    Argani, P
    Lal, P
    Hutchinson, B
    Lui, MY
    Reuter, VE
    Ladanyi, M
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) : 750 - 761
  • [3] Argani P, 2016, TITLEWORLD HLTH ORG
  • [4] Argani P, 2016, WHO CLASSIFICATION T
  • [5] Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum
    Argani, Pedram
    Olgac, Semra
    Tickoo, Satish K.
    Goldfischer, Michael
    Moch, Holger
    Chan, David Y.
    Eble, John N.
    Bonsib, Stephen M.
    Jimeno, Mireya
    Lloreta, Josep
    Billis, Athanase
    Hicks, Jessica
    De Marzo, Angelo M.
    Reuter, Victor E.
    Ladanyi, Marc
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (08) : 1149 - 1160
  • [6] MiT family translocation renal cell carcinoma
    Argani, Pedram
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2015, 32 (02) : 103 - 113
  • [7] Cytologic and cytogenetic diagnosis of pediatric renal cell carcinoma associated with t(X;17)
    Barroca, Helena
    Correia, Cecilia
    Castedo, Sergio
    [J]. ACTA CYTOLOGICA, 2008, 52 (03) : 384 - 386
  • [8] Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
    Bianchi, M.
    Sun, M.
    Jeldres, C.
    Shariat, S. F.
    Trinh, Q. -D.
    Briganti, A.
    Tian, Z.
    Schmitges, J.
    Graefen, M.
    Perrotte, P.
    Menon, M.
    Montorsi, F.
    Karakiewicz, P. I.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (04) : 973 - 980
  • [9] Bommer KK, 1997, CANCER CYTOPATHOL, V81, P148, DOI 10.1002/(SICI)1097-0142(19970625)81:3<148::AID-CNCR4>3.0.CO
  • [10] 2-N